Students will engage in problem-based learning to determine the cause of a described disease and find published sources that will help develop a treatment protocol. (The wrinkle is that students will not have the same access to information.)

Introductory lecture to 11th semester (international semester) in Medicine. General introduction to the concept of global health, and the importance of culture. Global health = local health, migrants health as an example

Introductory lecture to 11.semester (international semester) in Medicine. General introduction to the concept of global health, and the importance of culture. Global health = local health, migrants health as an example

Students learn about providing healthcare in a global setting and the importance of wearing protective equipment when treating patients with infectious diseases like Ebola. They learn about biohazard suits, heat transfer through conduction and convection and the engineering design cycle. Student teams design, create and test (and improve) their own Ebola biohazard suit prototypes that cover one arm and hand, including a ventilation system to cool the inside of the suit.

Episode 3 of the Swedish Global Health Podcast.
In April 2019, a youth-led panel with representatives from youth and student organizations and global health leaders took place at our house in Stockholm.

Before the panel, we had the opportunity to sit down with Peter Sands (Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria) and Dr Seth Berkley (CEO of Gavi the Vaccine Alliance) to discuss their respective work and personal engagement in global health. It became an interesting dialogue spanning over sustainable development goals, barriers to gain impact to achieve the 2030 agenda, the role of stakeholder engagement and reigniting global solidarity. We hope you enjoy it!
--------
The Swedish Global Health Podcast - A Podcast about Global Health and Sustainable Development is aimed at anyone interested in knowing more about this exciting topic! It is co-produced by the Swedish Society of Medicine's Committee for Global Health and the Swedish Society of Medicine's student and junior doctor section.

Episode 1, part 1: Interview with Sir Michael Marmot, Professor of Epidemiology and Public Health at University College London about the current state of Global Health, with special focus on Health Equity. The first episode consists of two parts.
-------
The Swedish Global Health Podcast - A Podcast about Global Health and Sustainable Development is aimed at anyone interested in knowing more about this exciting topic! It is co-produced by the Swedish Society of Medicine's Committee for Global Health and the Swedish Society of Medicine's student and junior doctor section.

Episode 1, part 2: Interview with Sir Michael Marmot and Rt Hon Helen Clark, former Prime Minister of New Zealand and Administrator of the United Nations Development Programme, about collaboration between public Health experts and politicians, evidence driven policy, gender equality and the way forward for global health.
-------
The Swedish Global Health Podcast - A Podcast about Global Health and Sustainable Development is aimed at anyone interested in knowing more about this exciting topic! It is co-produced by the Swedish Society of Medicine's Committee for Global Health and the Swedish Society of Medicine's student and junior doctor section.

In this episode 2 of the Swedish Global Health Podcast, we interview Dr. Angelina Kakooza, child neurologist and co-founder of the East African Academy of Childhood and Disability. We will discuss her work, research on developmental delays and disabilities, particularly the prevalence of and support for Children with cerebral palsy in Uganda. Dr. Kakooza also gives us some inside tips on successful South-North collaborations.
--------
The Swedish Global Health Podcast - A Podcast about Global Health and Sustainable Development is aimed at anyone interested in knowing more about this exciting topic! It is co-produced by the Swedish Society of Medicine's Committee for Global Health and the Swedish Society of Medicine's student and junior doctor section.

This is a video of 1 min and 33 seconds, showing an illustration of how acetylcholinesterase inhibitors work in the human body. This can be a useful video if you teach about pesticides and their health effects.

In this short video of 25 seconds we illustrate how organic solvents work. This can be a helpful demonstration in classes where you teach about organic solvents and health effects. Organic solvents dissolve fat. Here we watch two dishes. One contains water, the other contains white spirit. White spirit is a mixture of organic solvents which for instance is used in paint. When oil is added to the water, you see that the oil gathers in bubbles at the top, and the fat does not dissolve in the water. When oil is added to the white spirit, the oil immediately disappears, as it dissolves into the white spirit. This is how organic solvents work – they dissolve fat. This is relevant for humans because our nervous system is normally protected by fat tissue. The organic solvents remove this protection and harm the nerves and the brain.

The video below is from the main office of OSHA, Occupational Safety and Health Authority in Dar es Salaam, Tanzania, 2016. The video can be used to illustrate how such an unit is working; if you teach occupational Health.

This is a video clip of 1 min 36 seconds showing how to measure noise levels at a work place. You may use this video if you teach in occupational health about how to measure noise.

This video illustrates the difference between restrictive versus obstructive lung function impairment. The video can be used as a demonstration of these types of lung diseases in a lecture.

This a video of 45 seconds, showing an interview with a Tanzanian expert on pesticides; telling how dangerous pesticides can be for human Health. This can be used in teaching, to inspire students to learn about pesticides and health effects.

This is a short video clip demonstrating a prosthesis and made in a workshop producing such orthopaedic devices.

You can use the video for educational purposes if you teach about rehabilitation at the work place.

This is a video of 1 min 50 seconds which demonstrates how you can sample dust in a work environment. The video can be used for educational purposes if you teach this topic in occupational Health

This is a video clip of 45 seconds that show a construction work site in Asia, demonstrating noise, dust and vibration at this work place. You can use this video for teaching purposes if you teach occupational Health. Here these work exposures are demonstrated clearly.

This s a video of 1 min 27 seconds where you can see how a radiologist works and how he can become exposed to x-rays and how he can prevent radiation exposure.

You may use this to demonstrate this kind of work if you for instance teach in occupational health about radiation and Health.
The video is from Tanzania.

In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development. This Essay outlines how open source methods of working could be applied to the discovery and development of new medicines. There are many potential advantages of an open source approach, such as improved efficiency, the quality and relevance of the research, and wider participation by the scientific and patient communities; a blend of traditional and innovative financing mechanisms will have to be adopted. To evaluate properly the effectiveness of an open source methodology and its potential as an alternative model of drug discovery and development, we recommend that new projects be trialed and existing projects scaled up. Where we stand The scientific and medical community has discovered and developed many groundbreaking medicines that have had a major impact on public health. However, drug development is challenged by a widening gap between health needs and the pharmaceutical industry’s motives and business model, alongside a decrease in efficiency per research dollar spent in medicinal product research and development (R&D), a trend known colloquially as Eroom’s Law. Such fundamental challenges result in frequent high-level calls for new initiatives to develop therapeutics and bring them to market. These include market push and pull mechanisms such as priority review vouchers, advance market commitments, and public R&D funding. New organizational models have also emerged, including public–private partnerships (PPPs) and not-for-profit product development partnerships (PDPs) (for example, the Drugs for Neglected Diseases Initiative [DNDi], the Medicines for Malaria Venture [MMV], and the Global Alliance for Tuberculosis Drug Development [TB Alliance]) that often apply a full “de-linkage” model in which the price of medicines and the cost of R&D are uncoupled.